deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT03929484

A Feasibility Study Evaluating a Novel Mask (Nasal Reservoir Cannula)

A Feasibility Study Evaluating a Novel Mask (Nasal Reservoir Cannula) Plus Nasal Cannula vs. Nasal Cannula Alone for Supplemental Oxygen Delivery in the Treatment of Hospitalized Pediatric Patients With Hypoxemia Due to Severe Pneumonia

Sponsor: Infectious Diseases Research Collaboration, Uganda

Updated 4 times since 2019 Last updated: Apr 24, 2019 Started: Sep 1, 2017 Primary completion: Mar 31, 2018 Completion: Mar 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Per sponsor advice

Other terminated trials from Infectious Diseases Research Collaboration, Uganda

See all terminations from Infectious Diseases Research Collaboration, Uganda

Other Pneumonia Childhood trials with similar outcome

Browse all Pneumonia Childhood trials

This NA trial investigates Pneumonia Childhood and is currently terminated or withdrawn. Infectious Diseases Research Collaboration, Uganda leads this study, which shows 4 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~May 2019 – ~Jan 2021 · 20 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

4 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated NA

  4. May 2019 — Jan 2021 [monthly]

    Terminated NA

    First recorded

Sep 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Infectious Diseases Research Collaboration, Uganda
  • Intellectual Ventures
  • Makerere University
  • University of California, San Francisco
Data source: University of California, San Francisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations